|View printer-friendly version|
|April 14, 2003 4:35 p.m.|
|Teva Announces Approval of Hydrocodone Bitartrate and Ibuprofen Tablets|
Jerusalem, Israel, April 14, 2003 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U. S. Food and Drug Administration has approved the company's ANDA for Hydrocodone Bitartrate and Ibuprofen Tablets, 7.5 mg/200 mg. This approval follows a September 12, 2002 summary judgment decision in favor of Teva invalidating the patent asserted by Abbott. Abbott's appeal is pending. Shipment of this product will begin immediately.